Effect of tacrine, amiridine, akatinol memantine, and triazolam on phosphorylation, structure, and assembly of microtubules from brain microtubular proteins in Alzheimer diseases

Bulletin of Experimental Biology and Medicine

Volumn 145, Issue 2, 2008, Pages 218-222

  Shevtsov, P N ^a   Shevtsova, E F ^b   Burbaeva, G Sh ^a  

^a MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^b INSTITUTE OF PHYSIOLOGICALLY ACTIVE COMPOUNDS   (Russian Federation)

Author keywords

Alzheimer disease; Amiridine; Memantine; Microtubules; Tacrine

Indexed keywords

AMIRIDINE; MEMANTINE; MICROTUBULE ASSOCIATED PROTEIN; TACRINE; TRIAZOLAM; TUBULIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN TISSUE; MICROTUBULE ASSEMBLY; NEUROPROTECTION; PROTEIN ASSEMBLY; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE;

ALZHEIMER DISEASE; AMINOQUINOLINES; BRAIN; DOPAMINE AGENTS; GABA MODULATORS; HUMANS; MEMANTINE; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; NOOTROPIC AGENTS; PHOSPHORYLATION; TACRINE; TRIAZOLAM;

EID: 50649106187     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-008-0054-1     Document Type: Article

References (15)

1. S. I. Gavrilova, Neurodegenerative Diseases and Aging. Manual for Physicians [in Russian], Ed. I. A. Zavalishina, N. N. Yakhno, and S. I. Gavrilova, Moscow (2001), pp. 9-80.
2. P. N. Shevtsov, E. F. Shevtsova, G. Sh. Burbaeva, and S. O. Bachurin, Byull. Eksp. Biol. Med., 141, No. 2, 229-233 (2006).
3. A. D. Cash, G. Aliev, S. L. Seidlak, et al., Am. J. Pathol., 162, No. 5, 1623-1627 (2003).
4. R. Castellani, K. Hirai, G. Aliev, and K. L. Drew, J. Neurosci. Res., 70, 357-360 (2002).
5. H. Geerts, R. Nuydens, M. De Long, et al., J. Neurobiol. Aging, 17, 4573-4581 (1996).
6. R. H. Himes, P. R. Burton, and J. M. Gaito, J. Biol. Chem., 252, No. 17, 6222-6228 (1977).
7. B. Hutter-Paier, M. Fruhwirth, E. Grygar, and M. Windisch, J. Neural. Transm., 47, Suppl., 276 (1996).
8. M. W. Kirscner, R. C. Williams, M. Weingarten, and J. C. Gerhart, Proc. Natl. Acad. Sci. USA., 71, No. 4, 1159-1163 (1974).
9. K. D. Lahiri, M. R. Farlow, K. Sambamurti, et al., Current Drug Targets., 4, 97-112 (2003).
10. E. Mandelkow and E. M. Mandelkow, Cur. Opin. Cell. Biol., 7, 72-81 (1995).
11. S. S. Matsuyama and L. F. Jarvik, Proc. Natl. Acad. Sci. USA., 86, 8152-8156 (1989).
12. J. R. McCarten, C. Kovera, K. Mellita, et al., Pharmacol. Biochem. Behav., 52, No. 2, 447-452 (1995).
13. M. Paula-Barbosa, M. A. Tavares, and A. Cadeteleite, Brain Res., 417, No. 1, 139-142 (1987).
14. M. Tsolati, P. Sakka, O. Chatzizisi, et al., Alzheimer's Disease and Related Disorders, Eds. K. Iqbal et al., London (1999).
15. C. M. H. Watanabe, S. Wolffram, P. Ader, et al., Proc. Natl. Acad. Sci. USA., 98, No. 12, 6577-6580 (2001).